University of Pisa at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
University of Pisa takes part in 3 sessions at ESMO 2026 in Madrid. Its program centres on metastatic colorectal cancer, including clinical practice guidelines and later-line treatment options. It also covers a phase II trial using circulating tumour DNA to guide re-treatment with encorafenib and cetuximab in BRAF V600E-mutated disease that no longer responds to chemotherapy.
| Organization | ESMO 2026 Attendance |
|---|---|
University of Pisa Pisa, Italy | |
Public university in Pisa, Italy, with a school of medicine linked to the city's university hospital. | Talk Sat Oct 24 10:30–10:45 Metastatic colorectal cancer: Discussion Gastrointestinal cancersGynaecological cancers Satellite Sat Oct 24 13:40–14:00 Extending the continuum of care: Advances in later line treatment for mCRC Gastrointestinal cancers Abstract Sat Oct 24 14:45–14:50 |
Instantly find 20 buyers from University of Pisa
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction